Cure8
Is it always necessary to wait until day 5 for second line treatment in children with acute severe ulcerative colitis?
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Cure8 research brief

Is it always necessary to wait until day 5 for second line treatment in children with acute severe ulcerative colitis?

1 min read

Why This Matters

If reliable, an earlier day‑3 PUCAI cutoff could help identify children with flare‑related ASUC who are unlikely to respond to IV steroids and who may benefit from earlier planning for second‑line therapy rather than waiting to day 5.

Who Should Pay Attention

Pediatric gastroenterologists, inpatient clinicians, and parents/caregivers of children hospitalized with acute severe ulcerative colitis (especially flare‑related ASUC).

Study Snapshot

Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract

What To Know

This study included 91 biologic‑naïve children hospitalized with ASUC; about half required second‑line therapy.

For children whose ASUC occurred during a disease flare, a day‑3 PUCAI ≥50 showed high specificity (94.1%) and reasonable sensitivity (75%) for predicting steroid non‑response, and these patients had lower colectomy‑free rates and lower chance of clinical remission.

The authors conclude that in flare‑ASUC, a PUCAI ≥50 on day 3 could support earlier risk stratification and preparation for potential second‑line rescue therapy rather than waiting until day 5 per current guidelines.

Keep In Mind

Retrospective design and limited sample size mean results are hypothesis‑generating; this does not prove that earlier escalation improves outcomes. The extraction is from the article abstract.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
AuthorsLuca Scarallo, Arianna Bedeschi, Martina Di Benedetto +5 more
InstitutionGastroenterology and Nutrition Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedJul 24, 2026, 12:00 AM
Content availableJournal abstract

Conflict statement: Declaration of competing interest All authors declare no conflict of interest.

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →